156 related articles for article (PubMed ID: 37545531)
1. Disturbed lipid profile in common variable immunodeficiency - a pathogenic loop of inflammation and metabolic disturbances.
Jorgensen SF; Macpherson ME; Skarpengland T; Berge RK; Fevang B; Halvorsen B; Aukrust P
Front Immunol; 2023; 14():1199727. PubMed ID: 37545531
[TBL] [Abstract][Full Text] [Related]
2. Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency.
Macpherson ME; Skarpengland T; Hov JR; Ranheim T; Vestad B; Dahl TB; Fraz MSA; Michelsen AE; Holven KB; Fevang B; Berge RK; Aukrust P; Halvorsen B; Jørgensen SF
J Clin Immunol; 2023 Aug; 43(6):1229-1240. PubMed ID: 36995502
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
Front Immunol; 2020; 11():574500. PubMed ID: 33042155
[TBL] [Abstract][Full Text] [Related]
4. Altered Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency.
Skarpengland T; Macpherson ME; Hov JR; Kong XY; Bohov P; Halvorsen B; Fevang B; Berge RK; Aukrust P; Jørgensen SF
J Clin Immunol; 2022 Jan; 42(1):146-157. PubMed ID: 34669143
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications.
Jørgensen SF; Fevang B; Aukrust P
J Clin Immunol; 2019 Jan; 39(1):30-36. PubMed ID: 30465180
[TBL] [Abstract][Full Text] [Related]
6. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
[TBL] [Abstract][Full Text] [Related]
7. Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency.
Macpherson ME; Halvorsen B; Yndestad A; Ueland T; Mollnes TE; Berge RK; Rashidi A; Otterdal K; Gregersen I; Kong XY; Holven KB; Aukrust P; Fevang B; Jørgensen SF
Sci Rep; 2019 Jul; 9(1):9427. PubMed ID: 31263122
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
Kwiterovich PO
Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
[TBL] [Abstract][Full Text] [Related]
9. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.
Quispe R; Manalac RJ; Faridi KF; Blaha MJ; Toth PP; Kulkarni KR; Nasir K; Virani SS; Banach M; Blumenthal RS; Martin SS; Jones SR
Atherosclerosis; 2015 Sep; 242(1):243-50. PubMed ID: 26232164
[TBL] [Abstract][Full Text] [Related]
10. Higher Cardiovascular Risk in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients.
Vieira DG; Costa-Carvalho BT; Hix S; da Silva R; Correia MSG; Sarni ROS
Ann Nutr Metab; 2015; 66(4):237-241. PubMed ID: 26183722
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions.
Varricchi G; Poto R; Ianiro G; Punziano A; Marone G; Gasbarrini A; Spadaro G
Front Immunol; 2021; 12():712915. PubMed ID: 34408753
[TBL] [Abstract][Full Text] [Related]
12. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
[TBL] [Abstract][Full Text] [Related]
13. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Diabetic Dyslipidemia.
Hirano T
J Atheroscler Thromb; 2018 Sep; 25(9):771-782. PubMed ID: 29998913
[TBL] [Abstract][Full Text] [Related]
15. Gut inflammation exacerbates high-fat diet induced steatosis by suppressing VLDL-TG secretion through HNF4α pathway.
Li P; Chen X; Dong M; Luo J; Lu S; Chen M; Zhang Y; Zhou H; Jiang H
Free Radic Biol Med; 2021 Aug; 172():459-469. PubMed ID: 34186207
[TBL] [Abstract][Full Text] [Related]
16. Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN; Zhang YL; Hernandez-Ono A
Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
[TBL] [Abstract][Full Text] [Related]
17. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
18. Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation.
Jørgensen SF; Trøseid M; Kummen M; Anmarkrud JA; Michelsen AE; Osnes LT; Holm K; Høivik ML; Rashidi A; Dahl CP; Vesterhus M; Halvorsen B; Mollnes TE; Berge RK; Moum B; Lundin KE; Fevang B; Ueland T; Karlsen TH; Aukrust P; Hov JR
Mucosal Immunol; 2016 Nov; 9(6):1455-1465. PubMed ID: 26982597
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for microbiome-based approach in common variable immunodeficiency?
Poto R; Laniro G; de Paulis A; Spadaro G; Marone G; Gasbarrini A; Varricchi G
Clin Exp Med; 2023 Oct; 23(6):1981-1998. PubMed ID: 36737487
[TBL] [Abstract][Full Text] [Related]
20. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
